ArticleTherapeutic advances in medical oncology2026

Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.

Fatima Qadri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.